ATRC stock forecast
Our latest prediction for AtriCure, Inc.'s stock price was made on the Jan. 16, 2020 when the stock price was at 36.74$.
In the short term (2weeks), ATRC's stock price should underperform the market by -3.66%. During that period the price should oscillate between -7.32% and +6.08%.
In the medium term (3months), ATRC's stock price should underperform the market by -9.79%. During that period the price should oscillate between -26.51% and +15.56%.Get email alerts
Create a solid portfolio with ATRC
About AtriCure, Inc.
AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.
At the moment the company generates 231M USD in revenues.
On its last earning announcement, the company reported a loss of -0.94$ per share.
The book value per share is 4.51$
Three months stock forecastJan. 16, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|